Download de presentatie
De presentatie wordt gedownload. Even geduld aub
GepubliceerdDirk Bauwens Laatst gewijzigd meer dan 10 jaar geleden
1
CAT: Phystrac bij CTS Julie Staals Sept 2007
2
P : CTS I : tractie (Phystrac) C : geen / andere interventie O : klachtenverlichting
3
Cochrane CBO-richtlijn
Non-surgical treatment (other than steroid injection) for cts 2003 Geen tractie-therapie vermeld CBO-richtlijn Diagnostiek en behandeling van cts 2005
4
Pubmed (carpal tunnel syndrome AND traction)
New carpal ligament traction device for the treatment of cts unresponsive to conservative therapy. Porrata H, Porrata A, Sosner J. J Hand Ther. 2007;20(1):20-7. C-trac, niet beschikbaar Intermittend axial wrist traction as conservative treatment for cts: a case series. Brunarski D, Kleinberg B, Wilkins K. J Can Chiropr Assoc. 2004;48(3): 4 patiënten
5
pilot study Phystrac (1) Inclusie:
pilot study Phystrac (1) Inclusie: Klachten passend bij CTS Fysiotherapeut bevestigt diagnose
6
pilot study Phystrac (2)
12 patienten geincludeerd 12 behandelingen (12 weken) Evaluatie voor behandeling, na 2 en 3 mnd Inclusie, behandeling en evaluatie door fysiotherapeut Uitval n=3 (analyse n=9)
8
pilot study Phystrac (3) Controle groep:
proefschrift Gerritsen (2002) Polsspalk N=? The success rate was calculated with the general improvement score. In the traction group 4 out of 6 patients judged their condition as completely recovered or much improved after 12 weeks of treatment, resulting in a success rate of 66%. In the splinting group 46 out of 86 patients judged their condition as completely recovered or much improvement after 3 months of treatment, resulting in a success rate of 54%. No significant differences were found between de success rates of the traction group and the splinting group.
9
Conclusie Beter onderzoek nodig met (onder andere) meer patienten controlegroep, en langere follow-up duur
Verwante presentaties
© 2024 SlidePlayer.nl Inc.
All rights reserved.